Reference
Di Raimondo C, et al. Cemiplimab and ruxolitinib in concomitant cutaneous squamous cell carcinoma and myelofibrosis. Dermatologic Therapy 35: No. 5, May 2022. Available from: URL: https://onlinelibrary.wiley.com/doi/10.1111/dth.15421
Rights and permissions
About this article
Cite this article
Hydroxycarbamide. Reactions Weekly 1911, 227 (2022). https://doi.org/10.1007/s40278-022-17524-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-17524-6